Paper8733
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
Enna SJ and 4 others. Nature, 1976. Cited by 102 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Papers, record 8733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8733
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Butyrophenones | Major topic |
| Dibenzocycloheptenes | Major topic |
| Neurotransmitter Agents | Major topic |
| Receptors, Adrenergic | Major topic |
| Receptors, Drug | Major topic |
| Animals | |
| Binding, Competitive | |
| Biological Transport | |
| Brain | |
| Cattle | |
| Dopamine | |
| Haloperidol | |
| Ligands | |
| Lysergic Acid Diethylamide | |
| Membranes | |
| Molecular Conformation | |
| Phenothiazines | |
| Quinolizines | |
| Rats | |
| Serotonin | |
| Stereoisomerism | |
| Structure-Activity Relationship | |
| gamma-Aminobutyric Acid |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16,073,446 | Stereospecificity and clinical potency of neuroleptics. | https://conductscience.org/library/papers/16073446 |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,260,802 | The schizophrenia-associated variant in SLC39A8 alters protein glycosylation in the mouse brain. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/35260802 | PubMed |
| 32,753,748 | The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation. | Sci Rep | 2020 | https://conductscience.org/library/papers/32753748 | PubMed |
| 28,719,185 | Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins. | ACS Chem Biol | 2017 | https://conductscience.org/library/papers/28719185 | PubMed |
| 22,360,689 | From basic to clinical neuropharmacology: targetophilia or pharmacodynamics? | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22360689 | PubMed |
| 21,048,700 | The presynaptic component of the serotonergic system is required for clozapine's efficacy. | Neuropsychopharmacology | 2011 | https://conductscience.org/library/papers/21048700 | PubMed |
| 20,919,312 | The role of dopamine in the antipsychotic effect and the pathogenesis of schizophrenia. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919312 | PubMed |
| 6,777,797 | Supersensitivity to apomorphine in experimentally induced hypokinesia and drug-induced modifications of the apomorphine response. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6777797 | PubMed |
| 6,728,042 | 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors. | Naunyn Schmiedebergs Arch Pharmacol | 1984 | https://conductscience.org/library/papers/6728042 | PubMed |
| 6,583,691 | Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptosomes. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6583691 | PubMed |
| 6,124,232 | Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders. | Behav Genet | 1982 | https://conductscience.org/library/papers/6124232 | PubMed |
| 6,114,766 | Evidence for an inhibitory presynaptic component of neuroleptic drug action. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6114766 | PubMed |
| 2,984,638 | Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions. | Pharm Weekbl Sci | 1985 | https://conductscience.org/library/papers/2984638 | PubMed |
| 2,882,801 | Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone. | Br J Pharmacol | 1987 | https://conductscience.org/library/papers/2882801 | PubMed |
| 908,433 | Stereoselective activity of chiral neuroleptics. | Experientia | 1977 | https://conductscience.org/library/papers/908433 | PubMed |
| 714,184 | Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro. | Naunyn Schmiedebergs Arch Pharmacol | 1978 | https://conductscience.org/library/papers/714184 | PubMed |
| 435,685 | Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors? | Br J Pharmacol | 1979 | https://conductscience.org/library/papers/435685 | PubMed |
| 14,758 | Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings]. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/14758 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8733
GET https://conductscience.org/api/papers/v1/8733/authors